ArticleScientific reports2026
Differentiating Alzheimer's disease and vascular dementia via combined OCT and OCT‑angiography analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The purpose of this cross-sectional study is to compare microvascular and structural retinal parameters between Alzheimer’s disease (AD), vascular dementia (VD), and healthy controls (HC). We recruited AD and VD patients aged 50–90 years and age-matched HC who underwent ocular optical coherence tomography (OCT) and OCT angiography. Exclusion criteria included cataract, retinopathy, optic neuropathy, intraocular pressure ≥ 21 mmHg, and refractive error greater than + 4.0 D or less than − 4.0 D. The analysis included 118 participants: 29 with AD (14 female, mean age 70.0 ± 7.5), 30 with VD (11 female, mean age 69.9 ± 9.9) and 59 HC (28 females, mean age 69.7 ± 8.6 years). Parafoveal SCP VAD was slightly lower in AD than VD and HC (p = 0.034 overall ANOVA), while the difference between AD and HC was more pronounced in the inferior zone (p = 0.029). We found significantly thinner RNFL in VD than HC in superior, inferior and temporal quadrants (superior; 121.8 μm vs. 133 μm, p = 0.017, inferior; 126.6 μm vs. 137.3 μm, p = 0.017, temporal; 67.5 μm vs. 73.8 μm, p = 0.043). VD also had overall reduced macular thickness compared to AD, more pronounced in nasal perifoveal area (275.2 μm vs. 285.5 μm, p = 0.039). Overall, VD was characterized by pronounced RNFL and macular thinning, whereas AD exhibited parafoveal vascular density reduction without overt structural thinning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.